logologo
Search anything
arrow
WhatsApp Icon

Hindalco outlook 2026: Hold vs Buy as targets split

Hindalco and Persistent Systems are seeing renewed attention on Reddit and social feeds because fresh brokerage notes are landing with visibly different conclusions. For Hindalco, the discussion is driven by a strong March-quarter performance for FY2025, a dividend proposal, and debate on how much Novelis can rebound after disruptions. The stock is being framed as a mix of strong India execution and uneven near-term visibility at its global downstream arm. Persistent, meanwhile, is being discussed after brokerages reiterated Buy calls and raised target prices following Q3FY26 numbers. The common thread in both names is that the market is balancing growth visibility against valuation and near-term operating risks. Investors are also comparing how much of the good news is already priced in, given both stocks have been active in headlines. The tone of the online debate is not uniformly bullish, with “buy, hold, reduce” language appearing repeatedly across sources.

Hindalco: what stood out in the latest operating print

The context shared points to Hindalco delivering a largely in-line Q4 consolidated operating performance, supported by continued strong India performance. There was also mention of sequential improvement in Novelis, which matters because it has been the swing factor for consolidated earnings sentiment. At the same time, some notes cautioned that an ally hedging impact and the broader inflationary environment for fuel and raw materials could limit India FY27 EBITDA. This is an important nuance because it frames a strong operational base, but not an open-ended margin expansion story. Discussion also highlighted that captive mining is still a few quarters away. Separately, production start from Chakla was cited as delayed to Q4FY27 versus H1FY27 earlier. That delay has shown up in “wait and watch” commentary around the timing of cost benefits.

Novelis remains the key variable in the narrative

Online chatter repeatedly returns to Novelis because the recovery is described as ongoing and exposed to multiple moving parts. One note maintained a 6.5x multiple on Novelis, citing recovery from issues such as the Oswego fire incident, higher tariffs, higher leverage, and potential risk of higher scrap pricing. Motilal Oswal also flagged muted near-term earnings visibility from Novelis due to the Oswego fire as a likely overhang. In the same material, Novelis pricing got support from a record-high Midwest premium in North America cited at 70% of LME, which was described as supportive for scrap spreads and margins. Still, the debate is about durability, not just one quarter, particularly with tariff headwinds being referenced in multiple places. Consolidated leverage was cited at net debt-to-EBITDA of 1.7x as of December 2025, mainly due to the Novelis Bay Minette expansion. In short, the bull case leans on recovery and pricing, while the cautious case leans on uncertainty and cost risks.

Broker split: Buy calls stay, but Holds and Sells persist

The coverage snapshot in the context shows a wide range of targets and recommendations. Motilal Oswal Financial Services reiterated a BUY stance in one note with a SoTP-based target of ₹1,110 on Sep’27 estimates, while another Motilal Oswal note cited a target price of ₹790. Nuvama was cited as maintaining Buy with a target of ₹757, while Avendus maintained a Sell and raised its target price to ₹615-₹616, pointing to Novelis margin challenges and the risk of aluminium prices correcting by 10-15%. Emkay also maintained a Sell stance with a blended target price of ₹600, citing concerns around scrap cost and Novelis margins, while stating some concerns were already in the price. Another note downgraded the stock to Hold from Accumulate with a revised target price of ₹1,126, while keeping a 6.5x multiple on Novelis and raising the India business multiple to 7x EV of Mar’28E EBITDA. The summary conclusion in the shared material put the target range broadly at ₹650 to ₹1,110, which captures why social media is split.

Analyst distribution and key data points being quoted

Beyond individual notes, social posts are also referencing consensus-style snapshots. The “Mean Recos by 29 Analysts” section was described as having a Buy tilt on average, but also showing a “current” tag that appears as HOLD in one header. A separate distribution table listed Strong Buy 6, Buy 5, Hold 12, Sell 4, Strong Sell 2, totaling 29 analysts. An S&P Global Market Intelligence datapoint in the material stated 76.92% of analysts recommend a ‘BUY’, with an average target price of ₹748.3. MarketsMOJO’s Hold stance was also discussed as a balancing view, with a quality grade described as good and a debt-to-equity ratio cited at 0.48x as of 06 March 2026. The same source cited EV/CE of 1.4, ROCE of 13.6%, and PEG of 0.5, alongside earnings growth of 24.9% over the past year. However, it also flagged quarterly PBT (less other income) of ₹4,890 crore, down 10.1% versus the previous four-quarter average, and quarterly PAT of ₹3,939 crore, down 12.1%.

Quick table: what social media is quoting from broker notes

The following table consolidates the figures and viewpoints explicitly mentioned in the shared context.

CompanyBrokerage or sourceRating (as cited)Target price (as cited)Key points highlighted in the material
HindalcoMOFSLBuy₹1,110Positive on aluminium and copper tailwinds, strong balance sheet, Novelis overhang from Oswego fire, consolidated net debt-to-EBITDA 1.7x (Dec 2025)
HindalcoMotilal Oswal (another note)Buy₹790Strong India performance, Novelis EBITDA expected to rebound in H2 FY26, trading at 5.3x EV/EBITDA and 1.2x P/B on FY27 estimates
HindalcoAvendusSell₹615-₹616Novelis margin outlook challenging, margins near peak, aluminium price correction risk of 10-15%
HindalcoEmkaySell₹600Scrap cost and Novelis margin concerns, negative treatment and refining charges cited, valuation concerns linked to prior Novelis IPO expectations
HindalcoInvestec (as described)Hold (downgrade)₹1,126Novelis risks, tariffs, higher leverage, scrap risk, India FY27 EBITDA limited by inflation and hedging, Chakla start delayed to Q4FY27
Persistent SystemsNuvamaBuy₹7,700Broad-based growth, improving profitability, strong growth in Healthcare, BFSI, Hi-tech, deal momentum healthy
Persistent SystemsMotilal OswalBuy₹8,500Q3FY26 revenue $122m, 4.0% QoQ in dollars and 4.1% in constant currency, margin kicker
Persistent SystemsJM FinancialBuy₹7,600Target raised versus earlier ₹7,280, upside cited against prior close

Hindalco technical levels and price action being discussed

Some of the most repeated short-term references in the context are technical levels and recent price moves. One technical note cited the stock up 1.6% in the last 7 days and up 4.01% over the past 2 weeks. It also mentioned around 574 thousand shares changing hands for about ₹37.36 crore on a higher-volume day. Resistance was cited near ₹657.55 tied to a short-term moving average. Support was cited near ₹631.02 tied to a long-term moving average, with accumulated-volume support around ₹600.40 and ₹599.95, plus another support at ₹562.40. The same note included a probability-based three-month projection pointing to a potential -4.89% move with a range of ₹517.68 to ₹647.73. Separately, a headline note referenced an intraday move where the stock fell 1.6% to ₹652.50, even as the Sensex was up 0.6% at the time.

Persistent Systems: why broker targets moved higher

Persistent Systems is being discussed mainly through the lens of broker upgrades and reiterated Buy views after Q3FY26. Nuvama maintained a Buy rating and raised its target to ₹7,700 from ₹7,000, citing broad-based growth and improving profitability. Motilal Oswal reiterated Buy with a target of ₹8,500, calling the quarter “business as usual” but with an unexpected margin kicker. Motilal Oswal also cited Q3FY26 revenue of $122 million, up 4.0% quarter-on-quarter in dollar terms and 4.1% in constant currency, slightly ahead of estimates. Elara was cited as raising revenue estimates by 1-3% for FY27E and FY28E, aligning with Q4FY27 guidance, and revising earnings estimates up by 6-8% based on expected margin expansion. JM Financial was cited with a Buy call and a target of ₹7,600 versus an earlier ₹7,280. The same cluster of notes acknowledged premium valuations, but stayed constructive based on deal momentum and growth across verticals like Healthcare, BFSI, and Hi-tech.

What investors say they are watching next

For Hindalco, the near-term watchlist in the provided material is clear and largely operational. Investors are looking for clearer signals on Novelis earnings visibility after the Oswego fire and how tariffs and scrap spreads evolve. Several notes frame India operations as the stabiliser, but still highlight input-cost inflation and hedging effects that could limit FY27 EBITDA. The Chakla delay to Q4FY27 is also a reminder that some cost and resource-security benefits are not immediate. Brokerage commentary also points to capex intensity, including a five-year plan cited as about ₹45,000 crore in India and $1 billion in the US, which keeps focus on leverage and returns. For Persistent, the next checks are whether deal momentum remains robust and whether margin expansion assumptions hold over the next two years, as implied by the estimate revisions mentioned. Across both stocks, the social media takeaway is that the debate is less about direction and more about timing, with clear bulls, clear bears, and a large Hold camp in between.

Frequently Asked Questions

The shared notes show a split: multiple Buy calls (targets cited up to ₹1,110) alongside Holds and Sells driven mainly by Novelis visibility, tariffs, and scrap-cost risks.
Novelis is the key swing factor, with concerns cited around the Oswego fire overhang, tariff headwinds, higher leverage, and the risk of higher scrap pricing.
The material cites targets ranging from about ₹600 (Sell views) to ₹1,126 (a Hold downgrade note), with MOFSL’s Buy target at ₹1,110 also referenced.
Broker notes cited broad-based growth across verticals, healthy deal momentum, and improving profitability, with Q3FY26 revenue cited at $422 million and sequential growth in dollars and constant currency.
The cited levels include resistance near ₹657.55, support near ₹631.02, and accumulated-volume support around ₹600, with another support level mentioned at ₹562.40.

Did your stocks survive the war?

See what broke. See what stood.

Live Q4 Earnings Tracker